N-butyl lithocholic acid is a derivative of the secondary bile acid lithocholic acid. Lipid nanoparticles (LNPs) formulated with N-butyl lithocholic acid and encapsulating an mRNA vaccine encoding influenza hemagglutinin demonstrate reduced toxicity in the heart, spleen, and liver compared to LNPs containing cholesterol in mice.
Usually ships within 24 hours.